VHCP Management II as of June 30, 2018
Portfolio Holdings for VHCP Management II
VHCP Management II holds 18 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Endocyte | 17.8 | $59M | 4.3M | 13.80 | |
| Biohaven Pharmaceutical Holding | 16.7 | $56M | 1.4M | 39.52 | |
| Obseva Sa | 10.2 | $34M | 2.3M | 15.14 | |
| Ascendis Pharma A S (ASND) | 10.0 | $34M | 504k | 66.52 | |
| Argenx Se (ARGX) | 8.7 | $29M | 347k | 83.62 | |
| Tricida | 8.6 | $29M | 963k | 29.90 | |
| Zogenix | 4.8 | $16M | 362k | 44.20 | |
| BioCryst Pharmaceuticals (BCRX) | 4.2 | $14M | 2.5M | 5.73 | |
| Dbv Technologies S A (DBVT) | 3.6 | $12M | 463k | 25.97 | |
| Kiniksa Pharmaceuticals (KNSA) | 3.3 | $11M | 639k | 17.35 | |
| Bellerophon Therapeutics | 3.0 | $10M | 4.1M | 2.42 | |
| Momenta Pharmaceuticals | 2.6 | $8.7M | 425k | 20.45 | |
| Spero Therapeutics (SPRO) | 2.1 | $7.0M | 474k | 14.67 | |
| Kadmon Hldgs | 1.7 | $5.6M | 1.4M | 3.99 | |
| Ra Pharmaceuticals | 1.6 | $5.4M | 545k | 9.95 | |
| Marinus Pharmaceuticals | 0.7 | $2.4M | 345k | 7.07 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $654k | 30k | 22.01 | |
| Chemocentryx | 0.1 | $304k | 23k | 13.18 |
